Bringing the fundamentals into focus…
Back to CRISPR Therapeutics AG
How CRISPR Therapeutics AG stacks up
CRSP · against 217 other Healthcare companies of similar size
Growth
5/ 100
Near the bottom of its peers.
Ranked #213 of 218 · scores higher than 1% of peers
Bars: peers in each 10-point band of the growth score13 peers with a growth score of 0–9, including CRSP · Click a bar to see the companies
Why growth scores 5?
Weighted metrics compared with all Healthcare companies.Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over three years: weaker than 99% of peers. 3-year revenue growth: -57.1% vs peer median 5.8%
- slower revenue growth over the last year: weaker than 97% of peers. Revenue growth: -64.8% vs peer median 6.1%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = CRSP, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CRSP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 217 reported | -64.8% | 8.9% | 2% | 33% | |
| Earnings per share growthHigher is better · 139 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 210 reported | -57.1% | 9.0% | 1% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around CRSP| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 2.8B USD | 99 | 51 | |
| 5 | 19.7B HKD (≈$2.5B) | 98 | 84 | |
| 209 | 3.4B USD | 8 | 55 | |
| 211 | 24.9B CNY (≈$3.5B) | 7 | 38 | |
| 212 | 3.7B USD | 6 | 28 | |
| 213 | 17.6B CNY (≈$2.5B) | 5 | 11 | |
| 213 | 4.8B USD | 5 | 27 | |
| 213 | 4.6B USD | 5 | 29 | |
| 216 | 31.0B CNY (≈$4.3B) | 4 | 26 | |
| 216 | 7.8B USD | 4 | 30 | |
| 218 | 34.9B CNY (≈$4.9B) | 0 | 16 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score